Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population

Environmental and Molecular Mutagenesis

Volumn 47, Issue 9, 2006, Pages 725-732

  Canalle, Renata ^a   Andrade, Vanessa Da Silva S ^a   Scrideli, Carlos A ^a   De Paula Queiroz, Rosane G ^a   Tone, Luiz Gonzaga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Ethnic variability; Genetic polymorphism; TS; XPD; XRCC1

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; DNA; GLUTAMINE; LYSINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; THYMIDYLATE SYNTHASE; TRYPTOPHAN;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DNA REPAIR; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; MALE; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XPD GENE; XRCC1 GENE;

BRAZIL; CHILD; CHILD, PRESCHOOL; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THYMIDYLATE SYNTHASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 33845485311     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20269     Document Type: Article

References (68)

1. Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, Seifeldin IA, Levin B. 2000. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159:79-86.
2. Alves-Silva J, da Silva Santos M, Guimaraes PE, Ferreira AC, Bandelt HJ, Pena SD, Prado VF. 2000. The ancestry of Brazilian mtDNA line-ages. Am J Hum Genet 67:444-461.
3. Arruda VR, Grignolli CE, Goncalves MS, Soares MC, Menezes R, Saad ST, Costa FF. 1998. Prevalence of homozygosity for the deleted alleles of glutathione S-transferase μ (GSTM1) and θ (GSTT1) among distinct ethnic groups from Brazil: Relevance to environmental carcinogenesis? Clin Genet 54:210-214.
4. Au WW, Salama SA, Sierra-Torres CH. 2003. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111:1843-1850.
5. Baquet CR, Horm JW, Gibbs T, Greenwald P. 1991. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 83:551-557.
6. Benhamou S, Sarasin A. 2005. ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review. Am J Epidemiol 161:1-14.
7. Caldecott KW, Aoufouchi S, Johnson P, Shall S. 1996. XRCC1 polypeptide interacts with DNA polymerase β and possibly poly(ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 24:4387-4394.
8. Carvalho-Silva DR, Santos FR, Rocha J, Pena SD. 2001. The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68:281-286.
9. Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Mosig R, Selhub J, Ma J. 2003. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 12:958-962.
10. Choi SW, Mason JB. 2000. Folate and carcinogenesis: An integrated scheme. J Nutr 130:129-132.
11. Chu E, Allegra CJ. 1996. The role of thymidylate synthase in cellular regulation. Adv Enzyme Regul 36:143-163.
12. Danenberg PV, Malli H, Swenson S. 1999. Thymidylate synthase inhibitors. Semin Oncol 26:621-631.
13. David-Beabes GL, London SJ. 2001. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34:333-339.
14. Duarte MC, Colombo J, Rossit ARB, Silva AE. 2005. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 in a Brazilian population. Genet Mol Biol 28:397-401.
15. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. 2002. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 62:4630-4636.
16. Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530.
17. Graziano F, Kawakami K, Watanabe G, Ruzzo A, Humar B, Santini D, Catalano V, Ficarelli R, Merriman T, Panunzi S, Testa E, Cascinu S, Bearzi I, Tonini G, Magnani M. 2004. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. Int J Cancer 112:1010-1014.
18. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, Lin D, He F. 2004. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 64:4378-4384.
19. Hatagima A, Klautau-Guimarães MN, Silva FP, Cabello PH. 2000. Glutathione S-transferase M1 (GSTM1) polymorphism in two Brazilian populations. Genet Mol Biol 23:709-713.
20. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K. 2003. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88:159-166.
21. Hori T, Ayusawa D, Shimizu K, Koyama H, Seno T. 1984. Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Res 44:703-709.
22. Hori T, Ayusawa D, Glover TW, Seno T. 1985. Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cells. Jpn J Cancer Res 76:977-983.
23. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. 1995. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20:191-197.
24. Hu Z, Ma H, Chen F, Wei Q, Shen H. 2005. XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14:1810-1818.
25. Hung RJ, Hall J, Brennan P, Boffetta P. 2005. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 162:925-942.
26. Kamb A, Finer-Moore J, Calvert AH, Stroud RM. 1992. Structural basis for recognition of polyglutamyl folates by thymidylate synthase. Biochemistry 31:9883-9890.
27. Kawakami K, Omura K, Kanehira E, Watanabe Y. 1999. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19:3249-3252.
28. Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G, Danenberg PV. 2001. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7:4096-4101.
29. Kiuru A, Lindholm C, Heilimo I, Ceppi M, Koivistoinen A, Ilus T, Hirvonen A, Norppa H, Salomaa S. 2005. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ Mol Mutagen 46:198-205.
30. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. 1999. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59:2557-2561.
31. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. 2000. XPD polymorphisms: Effects on DNA repair proficiency. Carcinogenesis 21:551-555.
32. Marsh S. 2005. Thymidylate synthase pharmacogenetics. Invest New Drugs 23:533-537.
33. Marsh S, Collie-Duguid ES, Li T, Liu X, McLeod HL. 1999. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 58:310-312.
34. Marsh S, Ameyaw MM, Githang'a J, Indalo A, Ofori-Adjei D, McLeod HL. 2000. Novel thymidylate synthase enhancer region alleles in African populations. Hum Mutat 16:528.
35. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A, Vineis P. 2001. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92:562-567.
36. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T. 2006. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: A population-based case-control study. Carcinogenesis 27:1377-1385.
37. Mohrenweiser HW, Jones IM. 1998. Variation in DNA repair is a factor in cancer susceptibility: A paradigm for the promises and perils of individual and population risk estimation? Mutat Res 400:15-24.
38. Oliver FJ, Menissier-de Murcia J, de Murcia G. 1999. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64:1282-1288.
39. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J. 2006. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66:2860-2868.
40. Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S, Lenz HJ. 2001. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 1:65-70.
41. Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC. 2004. SNPs, haplotypes, and cancer: Applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 13:681-687.
42. Rossini A, Rapozo DC, Amorim LM, Macedo JM, Medina R, Neto JF, Gallo CV, Pinto LF. 2002. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 1:233-240.
43. Rossit AR, Cabral IR, Hackel C, da Silva R, Froes ND, Abdel-Rahman SZ. 2002. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett 180:173-182.
44. Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, Seeber S. 1997. Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors. J Clin Oncol 15:389-400.
45. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. 2004. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13:23-29.
46. Sancar A, Tang MS. 1993. Nucleotide excision repair. Photochem Photobiol 57:905-921.
47. Shen MR, Jones IM, Mohrenweiser H. 1998. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604-608.
48. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, Wang X, Spitz MR, Wei Q. 2000. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88:601-606.
49. Shi Q, Zhang Z, Neumann AS, Li G, Spitz MR, Wei Q. 2005. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis 26:649-656.
50. 399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12:1462-1467.
51. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ. 2002. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786-3791.
52. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW, Hu JJ. 2003. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190:183-190.
53. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. 2001. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10:125-131.
54. Stern MC, Johnson LR, Bell DA, Taylor JA. 2002. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004-1011.
55. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR, Wei Q. 2000. XPD/ERCC2 polymorphisms and risk of head and neck cancer: A case-control analysis. Carcinogenesis 21:2219-2223.
56. Tan W, Miao X, Wang L, Yu C, Xiong P, Liang G, Sun T, Zhou Y, Zhang X, Li H, Lin D. 2005. Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis 26:1430-1435.
57. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt SA, Arlett CF, Lehmann AR. 1997. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 94:8658-8663.
58. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW. 2001. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22:403-408.
59. Trapido EJ, Chen F, Davis K, Lewis N, MacKinnon JA. 1994. Cancer among Hispanic males in south Florida. Nine years of incidence data. Arch Intern Med 154:177-185.
60. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. 2002. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: Role in mutagen sensitivity. Carcinogenesis 23:1003-1008.
61. Wang LD, Guo RF, Fan ZM, He X, Gao SS, Guo HQ, Matsuo K, Yin LM, Li JL. 2005. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 18:177-184.
62. Weeda G, Hoeijmakers JH. 1993. Genetic analysis of nucleotide excision repair in mammalian cells. Semin Cancer Biol 4:105-117.
63. Xing D, Tan W, Wei Q, Lin D. 2002. Polymorphisms of the DNA repair gene XPD, risk of lung cancer in a Chinese population. Lung Cancer 38:123-129.
64. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. 2005. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: A case-control study in Taiwan. BMC Cancer 5:12.
65. Yin J, Li J, Vogel U, Wang H. 2005. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population. Biochem Genet 43:543-548.
66. Yu HP, Wang XL, Sun X, Su YH, Wang YJ, Lu B, Shi LY, Xiong CL, Li YY, Li F, Xu SQ. 2004. Polymorphisms in the DNA repair gene XPD, susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 154:10-15.
67. Zahm SH, Fraumeni JF Jr. 1995. Racial, ethnic, and gender variations in cancer risk: Considerations for future epidemiologic research. Environ Health Perspect 103:283-286.
68. Zhang X, Miao X, Liang G, Hao B, Wang Y, Tan W, Li Y, Guo Y, He F, Wei Q, Lin D. 2005. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65:722-726.